Pharmacology, Toxicology and Pharmaceutical Science
Relaxin
100%
Fibrosis
33%
Peroxisome Proliferator Activated Receptor
32%
Peroxisome Proliferator Activated Receptor Gamma
25%
Insulinase
25%
Receptor
22%
Liver Fibrosis
20%
Hyperglycemia
16%
Rapamycin
16%
Serelaxin
14%
Liver Injury
14%
Tacrolimus
14%
Smooth Muscle Actin
12%
Cytokine
11%
Sprague Dawley Rat
10%
Immunosuppressive Agent
9%
Glycoprotein E
8%
Virus Glycoprotein
8%
Hydroxychloroquine
8%
Fomepizole
8%
Fatty Acid
8%
Protein Kinases
8%
microRNA 155
8%
Ethanol
8%
Amylin
8%
Insulinoma
8%
Liver Protein
8%
Long Chain Fatty Acid
8%
Thioester
8%
Coenzyme A
8%
Chloroquine
8%
CYP27A1
8%
Pancreas Cancer
8%
Cell Protein
8%
Metformin
8%
Interleukin 6
8%
Tubulin
8%
Chronic Liver Disease
8%
Disease
8%
Relaxin 3
7%
Malignant Neoplasm
6%
Wound Healing
6%
Collagen Type 1
6%
Keyphrases
Relaxin
33%
Amylin
16%
Fibrosis
16%
Insulin-degrading Enzyme
16%
Insulin
13%
Hepatic Fibrosis
10%
Relaxin Receptor
9%
Proteasome Activity
9%
Amyloid Formation
8%
Virus Stability
8%
Receptor Expression
8%
Anti-migration Agent
8%
Cell Wall Proteins
8%
MicroRNA
8%
Ligand-independent
8%
Kinase Activation
8%
Approaches to Studying
8%
Peroxisome Proliferator-activated Receptor
8%
Peroxisomal Fatty Acid Oxidation
8%
S-nitrosylation
8%
Dominant Negative
8%
Relaxin Family Peptides
8%
Enzyme Function
8%
MicroRNA-155 (miR-155)
8%
Co-activation
8%
Ciliary Beating
8%
Polycation
8%
Nanoparticles
8%
Bronchial Epithelial Cells
8%
Enzyme Activity
8%
Liver Tissue
8%
Thyroid Cancer Cell Lines
8%
Hepatic Stellate Cells
8%
Antifibrotic Action
8%
Mutant Insulin
8%
Serelaxin
8%
Knockdown
8%
Changing Roles
8%
Alcoholic Liver Disease
8%
Nitric Oxide
8%
Protein Kinase
8%
Intact Cells
8%
Rat Liver
8%
Proteasome Complex
8%
Adipose Tissue Dysfunction
8%
Chronic Liver Disease
8%
Therapeutic Perspectives
8%
Chronic Liver Injury
8%
Phosphodiesterase-4 (PDE4)
8%
CXCR4 Inhibitor
6%
Biochemistry, Genetics and Molecular Biology
Insulin-Degrading Enzyme
46%
Insulysin
46%
Proteasome
36%
Protein Catabolism
26%
Enzyme
19%
Peroxisome Proliferator-Activated Receptor
16%
Relaxin
16%
Skeletal Muscle
10%
Insulin Resistance
10%
Insulin Degradation
9%
Copurification
9%
Ubiquitin
9%
Hyperglycemia
8%
Varicella Zoster Virus
8%
Posttranslational Modification
8%
Peroxisome Proliferator-Activated Receptor Gamma
8%
Fibrogenesis
8%
Insulin Receptor
8%
Thioester
8%
Coenzyme A
8%
Tubulin
8%
Hepcidin
8%
Wild Type
8%
Nelfinavir
8%
Hemocyte
8%
Protein Targeting
8%
Knockout Mouse
8%
Free Fatty Acids
6%
Sucrose
5%
Low Drug Dose
5%